Most Viewed Articles
| Articles | Fulltext downloads | PDF downloads | Total downloads |
|---|---|---|---|
Review ArticleRole of stem cell transplant in chronic myeloid leukemia in contemporary settingsFull text |  PDF Volume 10 | Issue 1 | January-April 2025DOI: 10.25259/IJMIO_15_2024 |
28,323 | 74,226 | 102,549 |
Case ReportNUTM1-BRD4 fusion mutation-positive salivary gland myoepithelial carcinoma: A diagnostic conundrumFull text | PDF Volume 10 | Issue 1 | January-April 2025DOI: 10.25259/IJMIO_2_2025 |
20,256 | 72,914 | 93,170 |
Case ReportGastric cancer or hodgkin lymphoma? Unraveling the diagnostic dilemma of primary gastric classical hodgkin lymphomaFull text | PDF Volume 10 | Issue 1 | January-April 2025DOI: 10.25259/IJMIO_28_2024 |
23,223 | 59,974 | 83,197 |
Case ReportCase report – Muir–Torre syndrome – A skin-deep manifestation of underlying malignancyFull text | PDF Volume 9 | Issue 3 | September-December 2024DOI: 10.25259/IJMIO_26_2024 |
15,315 | 67,419 | 82,734 |
Cardio Oncology with ACOSImmune checkpoint inhibitor-induced acute fulminant myocarditis: A case report and review of literatureFull text | PDF Volume 10 | Issue 1 | January-April 2025DOI: 10.25259/IJMIO_33_2024 |
22,142 | 58,567 | 80,709 |
Review ArticleAntibody-drug conjugate review in breast cancer: A targeted approachFull text | PDF Volume 9 | Issue 3 | September-December 2024DOI: 10.25259/IJMIO_30_2024 |
17,701 | 47,380 | 65,081 |
Short CommunicationOutcome of ivermectin and doxycycline in cancer patients with COVID-19: A positive experience in BangladeshFull text | PDF Volume 6 | Issue 1 | January-April 2021DOI: 10.25259/IJMIO_30_2020 |
57,843 | 5,818 | 63,661 |
Case ReportBreast carcinoma disguised as systemic sclerosis: A case report of unusual paraneoplastic syndromeFull text | PDF Volume 10 | Issue 1 | January-April 2025DOI: 10.25259/IJMIO_4_2024 |
20,657 | 41,810 | 62,467 |
Short CommunicationDriver mutations in oncogenesisFull text | PDF Volume 6 | Issue 2 | May-August 2021DOI: 10.25259/IJMIO_26_2020 |
51,926 | 8,986 | 60,912 |
Review ArticleGenetic diversity and variation in chronic myeloid leukemia patients of Indian origin- Implications for treatment response and prognosisFull text | PDF Volume 9 | Issue 3 | September-December 2024DOI: 10.25259/IJMIO_11_2024 |
15,739 | 38,751 | 54,490 |
Review ArticleEmerging strategies in cancer immunotherapy: Expanding horizons and future perspectivesFull text | PDF Volume 9 | Issue 3 | September-December 2024DOI: 10.25259/IJMIO_24_2024 |
25,604 | 28,040 | 53,644 |
Review ArticleEmerging role of immune checkpoint inhibitors in recurrent and metastatic head and neck squamous cell carcinomaFull text | PDF Volume 10 | Issue 3 | September-December 2025DOI: 10.25259/IJMIO_22_2025 |
15,819 | 33,939 | 49,758 |
Case ReportNivolumab-induced vitiligo in a patient treated for metastatic melanomaFull text | PDF Volume 10 | Issue 2 | May-August 2025DOI: 10.25259/IJMIO_10_2025 |
12,456 | 35,220 | 47,676 |
Case ReportReal life experience of complete remission with modified MEMMAT regimen with LACE induction followed by ASCT as consolidation in Recurrent Medulloblastoma -A case reportFull text | PDF Volume 10 | Issue 2 | May-August 2025DOI: 10.25259/IJMIO_31_2024 |
11,556 | 34,241 | 45,797 |
Case SeriesReal-world experience of chronomodulated prescription of cyclin-dependent kinases 4/6 inhibitor palbociclib in reducing hematological toxicity – A case seriesFull text | PDF Volume 10 | Issue 2 | May-August 2025DOI: 10.25259/IJMIO_34_2024 |
10,819 | 34,252 | 45,071 |
Original ArticleSpectrum of lymphomas in IndiaFull text | PDF Volume 9 | Issue 1 | January-April 2024DOI: 10.25259/IJMIO_18_2023 |
30,886 | 6,896 | 37,782 |
Review ArticleMini review: Molecular pathology of personalized medicine in cancer susceptibility syndromesFull text | PDF Volume 8 | Issue 3 | September-December 2023DOI: 10.25259/IJMIO_12_2023 |
30,867 | 5,186 | 36,053 |
Review ArticleIs continuous infusion of high-dose ifosfamide, a safe option? Drug reviewFull text | PDF Volume 5 | Issue 2 | May-August 2020DOI: 10.25259/IJMIO_21_2019 |
23,622 | 11,593 | 35,215 |
Original ArticleOutcomes with atezolizumab and bevacizumab in hepatocellular carcinoma – Real-world data from IndiaFull text | PDF Volume 8 | Issue 3 | September-December 2023DOI: 10.25259/IJMIO_15_2023 |
29,678 | 4,987 | 34,665 |
EditorialChallenging conventional wisdom in molecular oncology: New perspectivesFull text | PDF Volume 8 | Issue 3 | September-December 2023DOI: 10.25259/IJMIO_20_2023 |
28,725 | 5,008 | 33,733 |
Case ReportLong-term efficacy of osimertinib in de novo exon 19 deletion with T790M in an epidermal growth factor receptor mutated lung cancer patient in IndiaFull text | PDF Volume 9 | Issue 1 | January-April 2024DOI: 10.25259/IJMIO_16_2023 |
27,739 | 5,045 | 32,784 |
Review ArticleMolecular genetics changes in gallbladder carcinomaFull text | PDF Volume 5 | Issue 2 | May-August 2020DOI: 10.25259/IJMIO_19_2019 |
19,307 | 11,427 | 30,734 |
Review ArticleRedefining treatment-free remission criteria in chronic myeloid leukemia in IndiaFull text | PDF Volume 10 | Issue 1 | January-April 2025DOI: 10.25259/IJMIO_10_2024 |
26,339 | 3,690 | 30,029 |
Review ArticleMolecular oncology and the role of artificial intelligence in advancing cancer treatmentFull text | PDF Volume 8 | Issue 3 | September-December 2023DOI: 10.25259/IJMIO_17_2023 |
25,407 | 4,080 | 29,487 |
Case ReportClinical experience of total body irradiation performed on Halcyon™ for a patient diagnosed with acute myeloid leukemiaFull text | PDF Volume 7 | Issue 2 | May – August 2022DOI: 10.25259/IJMIO_5_2022 |
18,503 | 10,547 | 29,050 |
Case ReportSquamous cell carcinoma of lung presenting as “Sunray sign” in chest radiographFull text | PDF Volume 8 | Issue 3 | September-December 2023DOI: 10.25259/IJMIO_6_2023 |
22,101 | 6,563 | 28,664 |
Review ArticleHigh-dose nicotinamide, a histone deacetylase inhibitor (Sirtuin-1), can prevent emergence of treatment resistance in chronic myeloid leukemia – A perspectiveFull text | PDF Volume 9 | Issue 1 | January-April 2024DOI: 10.25259/IJMIO_1_2024 |
22,864 | 5,630 | 28,494 |
Review ArticlePatient perspectives on living with chronic myeloid leukemia in India: Quality of life, psychosocial support, and stigmaFull text | PDF Volume 9 | Issue 3 | September-December 2024DOI: 10.25259/IJMIO_17_2024 |
21,698 | 5,031 | 26,729 |
EditorialCrucial crossroads: Making the right choice for first-line therapy in advanced urothelial cancerFull text | PDF Volume 9 | Issue 1 | January-April 2024DOI: 10.25259/IJMIO_2_2024 |
19,890 | 6,555 | 26,445 |
Review ArticleUse of five-day chronomodulated prescription of palbociclib as myelopreservation drug along with Topotecan in recurrent extensive stage small cell lung carcinoma – A perspective articleFull text | PDF Volume 9 | Issue 1 | January-April 2024DOI: 10.25259/IJMIO_3_2024 |
20,460 | 5,752 | 26,212 |
Review ArticleUnderstanding immunotherapy and CAR-T-cells: A narrative reviewFull text | PDF Volume 9 | Issue 1 | January-April 2024DOI: 10.25259/IJMIO_22_2023 |
20,935 | 4,955 | 25,890 |
EditorialMisleading and Biased Lancet Editorial on Kashmir: What are the Authors Hiding?Full text | PDF Volume 4 | Issue 3 | September-December 2019DOI: 10.25259/IJMIO_8_2019 |
12,178 | 13,702 | 25,880 |
Review ArticleCan CDK 4/6 inhibitors be used in patients with visceral crises? Deviating from conventional teachingFull text | PDF Volume 7 | Issue 2 | May – August 2022DOI: 10.25259/IJMIO_8_2022 |
17,146 | 8,639 | 25,785 |
NewsEditorial board tribute to Dr. Amit VermaFull text | PDF Volume 6 | Issue 3 | September-December 2021 |
18,692 | 6,207 | 24,899 |
Brief CommentaryBioactive lipid: A novel diagnostic approach for retinoblastoma in clinical managementFull text | PDF Volume 6 | Issue 3 | September-December 2021DOI: 10.25259/IJMIO_7_2021 |
16,664 | 7,373 | 24,037 |
Review ArticleGenomic profiling of retinoblastoma using aqueous humor liquid biopsy – A rapid reviewFull text | PDF Volume 10 | Issue 1 | January-April 2025DOI: 10.25259/IJMIO_25_2024 |
21,872 | 1,595 | 23,467 |
Case ReportL1CAM expressing, ZFTA:: NCOA1 fusion-positive supratentorial ependymoma: A case reportFull text | PDF Volume 8 | Issue 3 | September-December 2023DOI: 10.25259/IJMIO_11_2023 |
18,037 | 5,277 | 23,314 |
Cardio Oncology with ACOSIbrutinib and atrial fibrillation as cardiotoxicity – A new safety warning that impacts overall survivalFull text | PDF Volume 7 | Issue 2 | May – August 2022DOI: 10.25259/IJMIO_1_2022 |
15,574 | 7,644 | 23,218 |
Review ArticleSignaling pathways in pancreatic ductile adenocarcinoma and potential therapeutic targetsFull text | PDF Volume 8 | Issue 3 | September-December 2023DOI: 10.25259/IJMIO_29_2022 |
17,935 | 5,235 | 23,170 |
Review ArticleThe Cancer Genomic Atlas – “TO CONQUER CANCER”Full text | PDF Volume 6 | Issue 2 | May-August 2021DOI: 10.25259/IJMIO_28_2020 |
15,261 | 7,888 | 23,149 |
Original ArticlePrevalence of germline mutations in women with breast and/or ovarian cancer in a tertiary care center in Pune, IndiaFull text | PDF Volume 8 | Issue 2 | May-August 2023DOI: 10.25259/IJMIO_5_2023 |
17,512 | 5,480 | 22,992 |
Case ReportComplete metabolic response with letrozole and palbociclib in advanced breast cancerFull text | PDF Volume 4 | Issue 3 | September-December 2019DOI: 10.25259/IJMIO_2_2019 |
13,774 | 9,163 | 22,937 |
Review ArticleMultiple myeloma: A saga of discoveriesFull text | PDF Volume 10 | Issue 3 | September-December 2025DOI: 10.25259/IJMIO_17_2025 |
9,263 | 13,309 | 22,572 |
Original ArticleIncorporation of immunohistochemistry in the assessment of survival and prognosis of endometrial cancers: Are we ready for the change?Full text | PDF Volume 7 | Issue 2 | May – August 2022DOI: 10.25259/IJMIO_2_2022 |
15,340 | 7,077 | 22,417 |
Review ArticlePost-chemotherapy maintenance treatment by nicotinamide riboside, a poly ADP ribose polymerase 1 inhibitor, in BRCA mutated advanced ovarian cancer – A perspectiveFull text | PDF Volume 6 | Issue 3 | September-December 2021DOI: 10.25259/IJMIO_12_2021 |
16,602 | 5,741 | 22,343 |
Review ArticleImmune dynamics of SARS-CoV-2 virus evolutionFull text | PDF Volume 7 | Issue 1 | January-April 2022DOI: 10.25259/IJMIO_26_2021 |
14,103 | 8,195 | 22,298 |
Review ArticleClinical trials landscape in Sri LankaFull text | PDF Volume 6 | Issue 2 | May-August 2021DOI: 10.25259/IJMIO_29_2020 |
16,499 | 5,719 | 22,218 |
Review ArticlePotential therapeutic molecular targets for better outcomes for patients with lung cancerFull text | PDF Volume 8 | Issue 2 | May-August 2023DOI: 10.25259/IJMIO_27_2022 |
18,533 | 3,525 | 22,058 |
Review ArticleMolecular genetic changes in gastric carcinomaFull text | PDF Volume 6 | Issue 1 | January-April 2021DOI: 10.25259/IJMIO_8_2020 |
12,180 | 9,855 | 22,035 |
Case ReportHyperthermic intraperitoneal chemotherapy in primary peritoneal cancer: Our experience in a young maleFull text | PDF Volume 6 | Issue 3 | September-December 2021DOI: 10.25259/IJMIO_16_2021 |
16,772 | 5,217 | 21,989 |